Experiments have been performed to clarify whether LHRH agonists might decrease growth of hormone-unresponsive prostate cancer in vivo. Male nude mice were injected s.c. with the human androgen-independent prostate tumor DU 145 cells; osmotic minipumps releasing the LHRH agonist Zoladex (LHRH-A) for
✦ LIBER ✦
Activation of the orphan nuclear receptor RORα induces growth arrest in androgen-independent DU 145 prostate cancer cells
✍ Scribed by Roberta M. Moretti; Marina Montagnani Marelli; Marcella Motta; Donatella Polizzi; Silvia Monestiroli; Graziella Pratesi; Patrizia Limonta
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 156 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0270-4137
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Growth-inhibitory effects of luteinizing
✍
Donatella Dondi; Roberta M. Moretti; Marina Montagnani Marelli; Graziella Prates
📂
Article
📅
1998
🏛
John Wiley and Sons
🌐
French
⚖ 131 KB
👁 2 views
The novel heterodinucleoside dimer 5-FdU
✍
R.M.C. Cattaneo-Pangrazzi; H. Schott; R.A. Schwendener
📂
Article
📅
2000
🏛
John Wiley and Sons
🌐
English
⚖ 323 KB
👁 2 views
BACKGROUND. We analyzed the cytotoxic properties of the new heterodinucleoside phosphate dimer 5-FdU-NOAC, which is composed of the cytotoxic drugs 5-FdU and N 4octadecyl-1--D-arabinofuranosylcytosine (NOAC) against human prostate tumor cells. METHODS. 5-FdU-NOAC effects on cell proliferation, cell